Discover
ABBV
AbbVie Inc.
249.94
1 x 249.28
1 x 249.36
bid
ask
+
1.97
0.79%
1 @ 03:59 PM
249.96 +0.02 (0.01%)
| Ytd | 9.39% | |
| 1y | 25.83% |
247.18
day range
250.77
190.75
52 week range
267.47
| Open | 248.20 | Prev Close | 247.97 | Low | 247.18 | High | 250.77 | Mkt Cap | 441.59B |
| Vol | 3.11M | Avg Vol | 6.81M | EPS | 10.19 | P/E | 24.53 | Forward P/E | 15.19 |
| Beta | 0.28 | Short Ratio | 2.42 | Inst. Own | 77.14% | Dividend | 6.92 | Div Yield | 2.81 |
| Ex Div Date | 07-15 | Earning | 07-31 | 50-d Avg | 241.74 | 200-d Avg | 225.18 | 1yr Est | 274.36 |
| Income Statement | |||
| Total Revenue | 16.99B | ||
| Revenues (USD) | 16.99B | ||
| Cost of Revenue | 4.29B | ||
| Gross Profit | 12.70B | ||
| Operating Expenses | 6.27B | ||
| Research and Development Expense | 2.34B | ||
| Selling, General and Administrative Expense | 3.63B | ||
| Operating Income | 6.43B | ||
| Interest Expense | 679.00M | ||
| Income Tax Expense | 662.00M | ||
| Net Income | 3.61B | ||
| Net Income Common Stock | 3.61B | ||
| Net Income Common Stock (USD) | 3.61B | ||
| Consolidated Income | 3.62B | ||
| Net Income to Non-Controlling Interests | 3.00M | ||
| Earnings per Basic Share | 2.04 | ||
| Earnings per Basic Share (USD) | 2.04 | ||
| Earnings per Diluted Share | 2.03 | ||
| Dividends per Basic Common Share | 1.73 | ||
| Earning Before Interest & Taxes (EBIT) | 4.95B | ||
| Earning Before Interest & Taxes (USD) | 4.95B | ||
| Weighted Average Shares | 1.77B | ||
| Weighted Average Shares Diluted | 1.77B | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.57B | ||
| Cash and Equivalents (USD) | 6.57B | ||
| Investments | 266.00M | ||
| Investments Non-Current | 266.00M | ||
| Trade and Non-Trade Receivables | 13.82B | ||
| Current Assets | 33.67B | ||
| Property, Plant & Equipment Net | 5.80B | ||
| Total Assets | 135.12B | ||
| Debt Current | 8.34B | ||
| Total Debt | 70.82B | ||
| Current Liabilities | 41.64B | ||
| Debt Non-Current | 62.48B | ||
| Total Liabilities | 141.05B | ||
| Accumulated Retained Earnings (Deficit) | -17.33B | ||
| Accumulated Other Comprehensive Income | -1.16B | ||
| Shareholders Equity | -5.98B | ||
| Shareholders Equity (USD) | -5.98B | ||
| Assets Non-Current | 101.45B | ||
| Total Debt (USD) | 70.82B | ||
| Goodwill and Intangible Assets | 84.66B | ||
| Inventory | 5.13B | ||
| Liabilities Non-Current | 99.41B | ||
| Trade and Non-Trade Payables | 33.30B | ||
| Tax Liabilities | 2.28B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.88B | ||
| Net Cash Flow from Financing | -5.05B | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.82B | ||
| Capital Expenditure | -322.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -824.00M | ||
| Issuance (Purchase) of Equity Shares | -9.00M | ||
| Issuance (Repayment) of Debt Securities | -2.00B | ||
| Payment of Dividends & Other Cash Distributions | -3.07B | ||
| Net Cash Flow from Investing | -1.20B | ||
| Net Cash Flow from Operations | 3.44B | ||
| Effect of Exchange Rate Changes on Cash | -7.00M | ||
| Share Based Compensation | 166.00M | ||